Latka logo
UDoTest logo

UDoTest

Boston, Massachusetts, United States

2021 Revenue

$238.5K

Funding

$0

Team

6

Founded

2017

UDoTest Revenue (2021)

UDoTest generated $238.5K in revenue in 2021.

Provider of cervical cancer, early detection, and human papillomavirus. The company operates within the industries of biotechnology, drug discovery, and other pharmaceuticals and biotechnology.

Last updated

UDoTest Revenue

In 2021, UDoTest's revenue reached $238.5K.

UDoTest Revenue GrowthReported revenue / ARR over time$0$60K$120K$180K$240K$300K20172018201920202021$0$238.5KSource: GetLatka.com
YearMilestoneSource
2021UDoTest Hit $238.5k revenue in April 2021Not recorded
2017Launched with $0 revenue

Founder / CEO

UDoTest Employees & Team Size

UDoTest employs approximately 6 people as of 2026.

UDoTest Team GrowthReported headcount over time023568201720182019202020210066Source: GetLatka.com
YearMilestoneSource
2021Reached 6 employees (April 2021)Not recorded

Frequently Asked Questions about UDoTest

Who owns UDoTest?

UDoTest is owned by Recuro Health, which acquired it.

What is UDoTest's revenue?

As of 2021, UDoTest generated $238.5K in revenue.

Who founded UDoTest?

UDoTest was founded by Allison Martin.

When was UDoTest founded?

UDoTest was founded in 2017.

How many employees does UDoTest have?

As of 2021, UDoTest had 6 employees.

Where is UDoTest headquartered?

UDoTest is headquartered in Boston, Massachusetts, United States.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile